Mumbai, May 11 (Udaipur Kiran): Shelter Pharma is currently trading at Rs. 32.11, up by 2.10 points or 7.00% from its previous closing of Rs. 30.01 on the BSE.
The scrip opened at Rs. 31.85 and has touched a high and low of Rs. 33.45 and Rs. 31.79 respectively. So far 63000 shares were traded on the counter.
The BSE group ‘M’ stock of face value Rs. 10 has touched a 52 week high of Rs. 50.00 on 25-Aug-2025 and a 52 week low of Rs. 26.50 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 33.84 and Rs. 29.00 respectively. The current market cap of the company is Rs. 54.80 crore.
The promoters holding in the company stood at 44.99%, while non-institutions held 55.01% stake in the company.
Shelter Pharma is launching a new healthcare/nutraceutical product, namely ‘FOLIMAN Folic Acid Tablets’ (Vitamin B-9 Supplement), on May 11, 2026, as part of its business expansion and product portfolio enhancement strategy. The launch is expected to strengthen the company’s presence in the healthcare segment and contribute towards future business growth. The product is being launched in the international market, and the company may subsequently introduce the same in the domestic market in due course.
Shelter Pharma is engaged in the business of manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
